Odomzo Approved for Advanced Skin Cancer

The FDA has approved Odomzo (sonidegib) capsules for the treatment of adults with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

Cancer Patients Need Fertility Preservation Awareness

Many young cancer patients have limited awareness about options to preserve their fertility.

ED Drugs and Melanoma Risk

Patients taking medications for erectile dysfunction (ED) may have an increased risk of melanoma but these drugs are not a cause of melanoma.

Chili Pepper Toxin, Gallbladder Cancer Risk

Gallbladder cancer seems to be associated with aflatoxin, according to a new study.

No Link Between PTSD, Cancer

While the potential relationship between stress and cancer has been a topic of discussion and research for over 70 years, no association between post-traumatic stress disorder (PTSD) and cancer was found in the largest study to date.

Cyramza Gains Colon Cancer Indication

The FDA has expanded the indication of Cyramza (ramucirumab; Eli Lilly) for use in combination with irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed on a first line bevacizumab-, oxaliplatin- and fluoropyrimidine-containing regimen.

Fish Oil May Hinder Chemotherapy Effectiveness

Fish oil supplements, and even certain fish, may hinder the effectiveness of chemotherapy.

Stroke Risk Up After Cancer Diagnosis

Cancer increases the risk of stroke independently of other stroke risk factors, such as hypertension and diabetes.

News

Elotuzumab BLA Given Priority Review for Multiple Myeloma

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for Empliciti (elotuzumab, Bristol-Myers Squibb/AbbVie) for the treatment of multiple myeloma as combination therapy in patients who have received one or more prior therapies.

Endoscopic Evaluation Advised in Non-Hodgkin's Lymphoma

Endoscopic Evaluation Advised in Non-Hodgkin's Lymphoma

For elderly adults diagnosed with non-Hodgkin's lymphoma, endoscopic evaluation may be recommended even in the absence of gastrointestinal symptoms.

Ultrasound, MRI Comparable for Cervical Cancer Staging in Study

Ultrasound, MRI Comparable for Cervical Cancer Staging in Study

Transvaginal sonography (TVS), performed by a dedicated gynecologic radiologist, is comparable to magnetic resonance imaging (MRI) for diagnosing and staging local cervical cancer.

Continuous Therapy Improves Survival in Multiple Myeloma

Continuous Therapy Improves Survival in Multiple Myeloma

In patients with newly diagnosed multiple myeloma, novel agent-based continuous therapy (CT) significantly improves progression-free survival and overall survival (OS) compared with fixed duration of therapy (FDT).

Physicians' Peers Influence Use of New Cancer Tx Modalities

Physicians' Peers Influence Use of New Cancer Tx Modalities

Physicians whose peers were early adopters of brachytherapy for the treatment of women with early-stage breast cancer are more likely to adopt the therapy themselves.

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from myCME

Comprehensive Review of Radiation OncologyExternal web site

Radiation oncologists and residents will appreciate the experience of the renowned faculty of the Comprehensive ...

CME 24.00 Credits

Chronic Pain ManagementExternal web site

This activity is designed to change health provider attitudes on chronic pain and willingness to ...

CME|CE 2.00 Credits

Prostate Cancer: Optimism, Caution for Active SurveillanceExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters